These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37726961)

  • 41. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: an observational study.
    Lio A; Rosati P; Pastorino R; Cota F; Tana M; Tirone C; Aurilia C; Ricci C; Gambacorta A; Paladini A; Mappa I; Buongiorno S; Zannoni GF; Romagnoli C; Vento G
    BMJ Open; 2017 Jul; 7(7):e015232. PubMed ID: 28729313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of Pregnancy Outcomes Among Women With Decreased Fetal Movements.
    Turner JM; Flenady V; Ellwood D; Coory M; Kumar S
    JAMA Netw Open; 2021 Apr; 4(4):e215071. PubMed ID: 33830228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial.
    Groten T; Lehmann T; Schleußner E;
    BMC Pregnancy Childbirth; 2019 Sep; 19(1):336. PubMed ID: 31521118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal low molecular weight heparin versus sildenafil citrate for fetal growth restriction: a randomized, parallel groups, open-label clinical trial.
    Rasheedy R; El Bishry G; Tarek R
    J Perinatol; 2020 May; 40(5):715-723. PubMed ID: 31695136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perinatal survival among very preterm singletons born after detection of early-onset fetal growth restriction with or without maternal hypertensive disorders: A population-based study in France.
    Anselem O; Goffinet F; Jarreau PH; Zeitlin J; Monier I
    Eur J Obstet Gynecol Reprod Biol; 2023 Mar; 282():43-49. PubMed ID: 36634405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical analysis of 31 cases of fetal umbilical artery thrombosis].
    Jiang RA; Xu T; Li W; Jin LF; Zhou YM; Bai XX; He J
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):495-500. PubMed ID: 37474322
    [No Abstract]   [Full Text] [Related]  

  • 49. OPtimal TIming of antenatal COrticosteroid administration in pregnancies complicated by early-onset fetal growth REstriction (OPTICORE): study protocol of a multicentre, retrospective cohort study.
    van de Meent M; Kleuskens DG; Ganzevoort W; Gordijn SJ; Kooi EMW; Onland W; van Rijn BB; Duvekot JJ; Kornelisse RF; Al-Nasiry S; Jellema RK; Knol HM; Manten GTR; Mulder-de Tollenaer SM; Derks JB; Groenendaal F; Bekker MN; Schuit E; Lely AT; Kooiman J
    BMJ Open; 2023 Mar; 13(3):e070729. PubMed ID: 36931680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fetal Growth Restriction in Hypertensive vs. Heavy Smoking Women-Placental Pathology, Ultrasound Findings, and Pregnancy Outcomes.
    Tairy D; Weiner E; Kovo M; Zamir AM; Gandelsman E; Levy M; Herman HG; Volpert E; Schreiber L; Bar J; Barda G
    Reprod Sci; 2021 Mar; 28(3):819-827. PubMed ID: 33140325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A late-preterm, early-term stratified analysis of neonatal outcomes by gestational age in placenta previa: defining the optimal timing for delivery.
    Balayla J; Wo BL; Bédard MJ
    J Matern Fetal Neonatal Med; 2015; 28(15):1756-61. PubMed ID: 25283850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.
    Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M
    Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sleep Apnea and Fetal Growth Restriction (SAFER) study: protocol for a pragmatic randomised clinical trial of positive airway pressure as an antenatal therapy for fetal growth restriction in maternal obstructive sleep apnoea.
    Hincker A; Nadler J; Karan S; Carter E; Porat S; Warner B; Ju YS; Ben Abdallah A; Wilson E; Lockhart EM; Ginosar Y
    BMJ Open; 2021 Jun; 11(6):e049120. PubMed ID: 34187829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maternal and Neonatal Outcomes of Iron Deficiency Anemia: A Retrospective Cohort Study.
    Safarzadeh S; Banihashemi F; Montazeri F; Roozbeh N; Darsareh F
    Cureus; 2023 Dec; 15(12):e51365. PubMed ID: 38292987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
    Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R
    Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gestational age at diagnosis of early-onset fetal growth restriction and impact on management and survival: a population-based cohort study.
    Monier I; Ancel PY; Ego A; Guellec I; Jarreau PH; Kaminski M; Goffinet F; Zeitlin J;
    BJOG; 2017 Nov; 124(12):1899-1906. PubMed ID: 28266776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
    Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Placenta-mediated pregnancy complications in women with a history of late fetal loss and placental infarction without thrombophilia: risk of recurrence and efficacy of pharmacological prophylactic interventions. A 10-year retrospective study.
    Borella F; Marozio L; Bertschy G; Botta G; Bertero L; Cassoni P; Maina A; Cosma S; Benedetto C
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2183748. PubMed ID: 36860098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of biochemical tests of placental function for improving pregnancy outcome.
    Heazell AE; Whitworth M; Duley L; Thornton JG
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.